GlobeNewswire

Hemlibra Emicizumab Sales Increase By 8% In 2023

Delhi, Feb. 29, 2024 (GLOBE NEWSWIRE) — Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029 Report Highlights: Bispecific Antibodies Development Proprietary Platforms Insight: > 30

Fobi AI Announces Completion of Non-Brokered Placement

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC, Feb. 28, 2024 (GLOBE NEWSWIRE) — Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company”

Scroll to Top